To achieve this, we continue to develop translational cell-specific and mechanism–based biomarkers, alongside model systems which have a well-defined physiological, pharmacological and immunological phenotype.
We explore how chemical and human (genetic and phenotype) factors influence the roles of adaptation, energy balance, degeneration and regeneration in DILI.
CDSS investigators
Back to: Centre for Drug Safety Science
